Companies /Healthcare

Johnson & Johnson

NYSE: JNJ Drug Manufacturers - General
$255.16
▲ $1.88 (+0.74%) today
Markets open · 2:39pm ET

JNJ Coverage Page 72

6:33am ET
Investing

Media Digest (11/7/2012) Reuters, WSJ, NY Times, FT

thinkstockAmazon.com Inc. (NASDAQ: AMZN) will be able to sell cheaper e-books. (Reuters) Amazon is likely to win its showdown of e-books in Europe with Apple Inc. (NASDAQ: AAPL) as the loser. (Reuters)…

Douglas A. McIntyre
9:02am ET
Health and Healthcare

Abbott Labs Q3 Profit Surges, but Revenues Slip

Abbott Laboratories (NYSE: ABT) said that third-quarter earnings surged, despite a slip in revenue, due to a double-digit decline in expenses. The health care company posted adjusted earnings per share (EPS) of…

Trey Thoelcke
4:05pm ET
Investing

24/7 Wall St. Closing Bell — October 16, 2012: Markets Up on Consumer Confidence, Homebuilders (S, RVBD, WPI, HAL, KR, PKG, WDFC, FRX, GS, JNJ, MAT, PNC, KO, UNH, GWW, WWW, C, INTC, IBM, CSX, URI, ABT, BK, BLK, CHKP, CMA, HAL, KCG, PEP, USB, CLWR, RATE, NOK, MSFT)

The three major U.S. stock indexes opened higher this morning following a report that economic sentiment in Germany came in better than expected (more coverage here) and that U.K. inflation was lower…

Paul Ausick
8:07am ET
Health and Healthcare

Johnson & Johnson Tops Earnings Expectations

Johnson & Johnson (NYSE: JNJ) reported fiscal third-quarter results before markets opened this morning. The health care giant posted earnings per share (EPS) of $1.25 on revenues of $17.1 billion. In the…

JNJ
Trey Thoelcke